MK-8504

MK-8504 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8504, covering 2019-07-15 to 2019-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002) [Phase 1]

See pricing